Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening for activating EGFR mutations in surgically resected nonsmall cell lung cancer.

The European respiratory journal - 1 Oct 2011

Sriram K B, Tan M E, Savarimuthu S M, Wright C M, Relan V, Stockwell R E, Clarke B E, Duhig E E, Yang I A, Bowman R V, Fong K M

Abstract excerpt

The clinical applicability of screening surgically resected nonsmall cell lung cancer (NSCLC) tumour tissue and serum for activating epidermal growth factor receptor (EGFR) mutation is unknown. Furthermore, the comparative accuracy of inexpensive EGFR mutation tests, mutant-enriched (ME)-PCR and high-resolution melt (HRM) has not been determined. Lung tumour DNA from 522 surgically resected stage I-IV NSCLC and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Lung Neoplasms

Share to Reproducibility of Results

Share to Sensitivity and Specificity

Share to Transition Temperature

Source

Identifiers

PMID: 21349912
DOI: 10.1183/09031936.00190110

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening for activating EGFR mutations in surgically resected nonsmall cell lung cancer.PMID 21349912Read ↗

Detection of epidermal growth factor receptor gene mutations in cytology specimens from patients with non-small cell lung cancer utilising high-resolution melting amplicon analysis.Semantic proximity Read ↗

Nonenriched PCR Versus Mutant-Enriched PCR in Detecting Selected Epidermal Growth Factor Receptor Gene Mutations Among Nonsmall-Cell Lung Cancer Patients.Semantic proximity Read ↗

Detection of EGFR mutations in patients with non-small cell lung cancer by high resolution melting. Comparison with other methods.Semantic proximity Read ↗

High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies.Semantic proximity Read ↗

Epidermal growth factor receptor mutations in non-small cell lung cancer undetected by high-sensitivity allele-specific real-time polymerase chain reaction-based assays.Semantic proximity Read ↗

Direct serum and tissue assay for EGFR mutation in non-small cell lung cancer by high-resolution melting analysis.Semantic proximity Read ↗

Detection of EGFR-TK domain-activating mutations in NSCLC with generic PCR-based methods.Semantic proximity Read ↗

Detection of<i>EGFR</i>Mutations in Archived Cytologic Specimens of Non–Small Cell Lung Cancer Using High-Resolution Melting AnalysisSemantic proximity Read ↗

Detection of epidermal growth factor receptor mutations in formalin fixed paraffin embedded biopsies in Malaysian non-small cell lung cancer patients.Semantic proximity Read ↗

Evaluation of 2-year experience with EGFR mutation analysis of small diagnostic samples.Semantic proximity Read ↗

Screening for EGFR and KRAS mutations in endobronchial ultrasound derived transbronchial needle aspirates in non-small cell lung cancer using COLD-PCR.Semantic proximity Read ↗

Radiologic Characteristics of Surgically Resected Non-Small Cell Lung Cancer With ALK Rearrangement or EGFR Mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.